Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -10.72%29.31B | 29.18%57.85B | 55.07%32.83B | 33.06%44.78B | 17.90%21.17B | -5.66%33.66B | 6.72%17.95B | 21.40%35.68B | 39.56%16.82B | -10.42%29.39B |
| Operating income | -10.72%29.31B | 29.18%57.85B | 55.07%32.83B | 33.06%44.78B | 17.90%21.17B | -5.66%33.66B | 6.72%17.95B | 21.40%35.68B | 39.56%16.82B | -10.42%29.39B |
| Cost of sales | 10.04%-28.79B | -30.86%-56.23B | -57.36%-32B | -32.25%-42.97B | -16.03%-20.34B | 5.56%-32.49B | -8.06%-17.53B | -21.21%-34.41B | -37.72%-16.22B | 10.70%-28.39B |
| Operating expenses | 10.04%-28.79B | -30.86%-56.23B | -57.36%-32B | -32.25%-42.97B | -16.03%-20.34B | 5.56%-32.49B | -8.06%-17.53B | -21.21%-34.41B | -37.72%-16.22B | 10.70%-28.39B |
| Gross profit | -37.41%514.22M | -10.70%1.62B | -1.11%821.56M | 55.63%1.81B | 94.67%830.81M | -8.25%1.17B | -29.37%426.77M | 26.97%1.27B | 117.07%604.22M | -1.67%1B |
| Selling expenses | -53.24%-24.81M | -22.35%-26.78M | 61.11%-16.19M | 43.51%-21.89M | -132.38%-41.63M | 22.61%-38.75M | 24.26%-17.92M | 12.24%-50.08M | 11.97%-23.66M | 2.25%-57.06M |
| Administrative expenses | 8.75%-305.69M | -16.30%-861.88M | -39.96%-335.02M | -78.57%-741.08M | -34.53%-239.37M | -5.30%-415M | 4.82%-177.93M | -24.87%-394.12M | -26.18%-186.94M | 10.01%-315.62M |
| Impairment and provision | 55.73%1.09M | 87.83%-1.73M | 142.41%698K | -125.18%-14.18M | -106.78%-1.65M | 211.81%56.31M | 149.08%24.28M | -2.32%-50.36M | -30.69%-49.47M | 47.61%-49.22M |
| -Other impairment is provision | 55.73%1.09M | 87.83%-1.73M | 142.41%698K | -125.18%-14.18M | -106.78%-1.65M | 211.81%56.31M | 149.08%24.28M | -2.32%-50.36M | -30.69%-49.47M | 47.61%-49.22M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 25.93%-336.76M |
| Special items of operating profit | 130.58%54.13M | 13.60%-168.13M | 113.80%23.48M | 48.50%-194.58M | -224.41%-170.13M | -3,917.92%-377.86M | -472.16%-52.44M | -88.84%9.9M | -78.61%14.09M | -46.63%88.71M |
| Operating profit | -51.68%238.94M | -33.34%561.62M | 30.81%494.53M | 115.77%842.54M | 86.44%378.04M | -50.31%390.49M | -43.40%202.76M | 137.63%785.88M | 172.72%358.25M | 46.18%330.72M |
| Financing cost | 8.73%-235.24M | 7.94%-509.78M | -7.66%-257.74M | -69.28%-553.77M | -57.65%-239.41M | -4.06%-327.13M | 3.23%-151.86M | ---314.37M | 12.59%-156.93M | ---- |
| Share of profits of associates | -49.78%-674K | ---1.57M | ---450K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -98.72%3.02M | -82.59%50.27M | 70.49%236.34M | 355.83%288.78M | 172.35%138.62M | -86.56%63.35M | -74.72%50.9M | 42.57%471.52M | 517.82%201.32M | 46.18%330.72M |
| Tax | 90.08%-8.79M | 52.87%-40.67M | -63.05%-88.58M | -23.67%-86.28M | -118.94%-54.33M | 48.30%-69.77M | 62.97%-24.81M | -363.97%-134.94M | -2,829.95%-67.01M | 44.81%-29.08M |
| After-tax profit from continuing operations | -103.90%-5.76M | -95.26%9.6M | 75.28%147.76M | 3,256.11%202.5M | 223.14%84.3M | -101.91%-6.42M | -80.58%26.09M | 11.58%336.58M | 366.12%134.31M | 73.81%301.64M |
| Earning after tax | -103.90%-5.76M | -95.26%9.6M | 75.28%147.76M | 3,256.11%202.5M | 223.14%84.3M | -101.91%-6.42M | -80.58%26.09M | 11.58%336.58M | 366.12%134.31M | 73.81%301.64M |
| Minority profit | -94.12%4.14M | -111.82%-30.6M | 5.05%70.32M | 320.60%258.82M | 373.30%66.94M | -334.00%-117.33M | -433.45%-24.49M | 1,149.17%50.14M | 119.88%7.35M | -117.78%-4.78M |
| Profit attributable to shareholders | -112.78%-9.9M | 171.36%40.2M | 346.04%77.44M | -150.79%-56.33M | -65.67%17.36M | -61.28%110.91M | -60.16%50.58M | -6.52%286.44M | 1,039.49%126.96M | 108.92%306.42M |
| Basic earnings per share | -113.95%-0.0006 | 170.97%0.0022 | 330.00%0.0043 | -150.00%-0.0031 | -64.29%0.001 | -61.25%0.0062 | -60.56%0.0028 | -6.43%0.016 | 987.50%0.0071 | 108.54%0.0171 |
| Diluted earnings per share | -113.95%-0.0006 | 170.97%0.0022 | 330.00%0.0043 | -150.00%-0.0031 | -64.29%0.001 | -61.25%0.0062 | -60.56%0.0028 | -6.43%0.016 | 987.50%0.0071 | 108.54%0.0171 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin Yong Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin Yong Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.